Skip to content

The value of combined detection of different blood biomarkers in the diagnosis and treatments of traumatic brain injury

The value of combined detection of different blood biomarkers in the diagnosis and treatments of traumatic brain injury

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098335
Enrollment
Unknown
Registered
2025-03-06
Start date
2025-03-15
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Traumatic Brain Injury

Interventions

Control group:NA
TBI group:NA

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Brain injury patients aged 18 - 65 years old. 2. Time of injury: patients with acute traumatic brain injury within 24h; 3. Glasgow Coma Scale (Glasgow Coma Scale, GCS) score: 13 to 15 for patients with mild traumatic brain injury, 9 to 12 for moderate traumatic brain injury, and 3 to 8 for patients with severe traumatic brain injury; 4. No other system damage has occurred in traumatic brain injury patients; 5. Admitted to hospital for the first diagnosis after the brain injury; 6. Age range of fracture patients: 18 - 65 years old. 7. Injury time: Patients with simple fractures of the limbs or spine within 24 hours; 8. The fracture patient has no other systemic injuries. 9. First visit and hospital admission after fracture;

Exclusion criteria

Exclusion criteria: 1. With a history of neurological or psychiatric disorders; 2. Traumatic brain injury occurred before the injury; 3. Alcohol consumption, substance abuse during or within the previous 24 hours; 4. Mild brain trauma is a complication of other injuries (systemic trauma, facial trauma, or spinal cord trauma) or other causes (psychological trauma, language impairment); 5. Patients without visits, and incomplete data during treatment;

Design outcomes

Primary

MeasureTime frame
Glasgow Coma Scale,GCS;

Secondary

MeasureTime frame
Full Outline of Unresponsiveness, FOUR;P-VAS;Montreal Cognitive Assessment,MoCA;Blood biomarkers: NSEGFAPS100BTauMBP;Cerebrospinal fluid markers: NSEGFAPTauNFL;

Countries

China

Contacts

Public ContactZhuonan Wang

The First Affiliated Hospital of Xi'an Jiaotong University

wangzhuonan424@126.com+86 29 85324741

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026